Evaluation of Oxidative Stress and Inflammation Markers in Temporomandibular Disorders
The Evaluation of Oxidative Stress and Inflammation Markers in Serum and Saliva of the Patients With Temporomandibular Disorders
1 other identifier
observational
44
1 country
1
Brief Summary
Background: The occurrence of many diseases has been associated with oxidative stress and disruption of antioxidant mechanisms. Temporomandibular Joint(TMJ) Disorders are also thought to develop with the onset of the destructive process in the tissues as a result of this balance being disrupted. Purpose: This study was designed to compare salivary and serum oxidative stress and inflammation markers of individuals with Temporomandibular Disorders (TMD) and healthy subjects. Study design, setting, and sample: A prospective cross-sectional study was conducted. 27 TMD patients diagnosed with disc displacement (DD) according to RDC/TMD and 17 healthy subjects were enrolled in the study. Prior to any treatment, serum and saliva samples were taken from the patients and centrifuged, and stored at -80°C until analyzed. All samples were examined for IL-6, MDA and 8-OHdG concentrations. Predictor variable: Diagnosis of disc displacement (RDC/TMD) Main outcome variables: Levels of 8-OHdG, IL-6 and MDA Covariates: Age and gender
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 19, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 19, 2023
CompletedFirst Submitted
Initial submission to the registry
July 26, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedAugust 14, 2023
August 1, 2023
2.8 years
July 26, 2023
August 3, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
relationship between serum and salivary 8-OHdG, IL-6 and MDA levels
relationship between serum and salivary 8-OHdG, IL-6 and MDA levels and Temporomandibular Disorders were evaluated
through study completion, an average of 1 year
Study Arms (2)
Study group
patients who applied to our clinic with complaint of pain in TMJ region subjects who had RDC/TMD type II disorder
Control group
age and sex matched healthy volunteers
Interventions
Oxidative stress and inflammation markers were analyzed in serum and saliva of TMD and healthy subjects.
Eligibility Criteria
TMD subjects who had RDC/TMD type II disorder (TMJ disc displacement (DD) with reduction, TMJ-DD without reduction with limited opening, TMJ-DD without reduction without limited opening) and, age and sex matched volunteers were included as the control group
You may qualify if:
- TMD subjects who had RDC/TMD type II disorder (TMJ disc displacement (DD) with reduction
- TMJ-DD without reduction with limited opening
- TMJ-DD without reduction without limited opening)
You may not qualify if:
- other local or systemic diseases,
- pain of dental origin,
- pregnancy or lactation,
- story of the use of anti-inflammatory drugs, analgesics, muscle relaxants, vitamin C or vitamin E,
- smoking,
- individuals who had already been under treatment for TMD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bahcesehir University
Istanbul, Beşiktaş, 34357, Turkey (Türkiye)
Biospecimen
saliva serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dilara Kazan
Bahçeşehir University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 26, 2023
First Posted
August 14, 2023
Study Start
June 19, 2020
Primary Completion
March 28, 2023
Study Completion
April 19, 2023
Last Updated
August 14, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share